false statements

ImmunityBio faces class action securities fraud lawsuit over allegedly false Anktiva drug claims. Schall Law Firm recruiting investors who purchased stock January-March 2026.

The Gross Law Firm filed a securities class action against $GLOB for allegedly misrepresenting Latin American operations as stable while facing declining demand and wage freezes.

The Schall Law Firm is investigating $EPSM for potential securities fraud, including false statements and failure to disclose material information to shareholders.

Schall Law Firm investigates Diginex Limited for alleged false statements and material disclosure failures. Firm seeks affected shareholders who suffered losses.

Schall Law Firm investigates $CURX for potential securities fraud, alleging false statements and material disclosure failures. Harmed shareholders invited to participate.

Rosen Law Firm urges $TCOM investors to act before May 11, 2026 deadline in securities fraud lawsuit alleging false statements about regulatory risks.

Rosen Law Firm urges $ALDX investors to act before May 29, 2026 deadline in securities class action alleging false reproxalap trial disclosures.

Class action lawsuit filed against $GEMI alleging false statements on crypto platform viability and overstated expansion plans. Lead plaintiff deadline May 18, 2026.

Rosen Law Firm solicits $MEDP investors for class action lawsuit alleging false statements about backlog cancellation rates between April 2025 and February 2026.

Apollo Global Management faces securities lawsuit over alleged false statements regarding executive ties to Jeffrey Epstein. Lead plaintiff deadline: May 1, 2026.

Rosen Law Firm urges $ALIT investors to join securities lawsuit by May 15, 2026 deadline, alleging false financial statements and undisclosed compensation costs.

Rosen Law Firm urges $SMCI investors to join securities class action alleging undisclosed export violations and compliance weaknesses. Lead plaintiff deadline: May 26, 2026.

Class action filed against $CHOW alleging securities fraud, false statements, and undisclosed market-manipulation scheme involving social media misinformation and fraudulent trading.

Class action lawsuit filed against $ATARA alleging securities fraud over false statements regarding manufacturing issues and ALLELE study deficiencies affecting tabelecleucel approval prospects.

Schall Law Firm files securities fraud class action against $ZSPC following December 2024 IPO, citing false disclosures and undisclosed preferred shareholder details.

Schall Law Firm recruits $POET investors for class action lawsuit alleging false statements about tax status and business prospects.

Securities class action alleges $BSX concealed unsustainable growth in electrophysiology segment, leading to earnings miss. Lead plaintiff deadline set for May 4, 2026.

The Schall Law Firm is investigating Perimeter Solutions for potential securities fraud, claiming the company made false statements or failed to disclose material information to investors.

Law firm launches investigation into Kairos Pharma for potential securities violations involving false statements and material disclosure failures.

Rosen Law Firm alerts Babcock & Wilcox investors of June 15 deadline in securities class action alleging false statements about Applied Digital contract and undisclosed shareholder ties.